Status:
RECRUITING
Evaluation of VISIOCYT Bladder Cytology in Real Life
Lead Sponsor:
Institut Paoli-Calmettes
Conditions:
Bladder Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The study will be offered to all consecutive patients undergoing scheduled cystoscopy at the Hospitalisation De Jour (HDJ) Chirurgicale, either as part of a diagnostic approach in the event of suspect...
Eligibility Criteria
Inclusion
- Patient over 18 years of age,
- Signed consent to participate,
- Affiliation with a social security scheme, or beneficiary of such a scheme,
- Patient to undergo cystoscopy for diagnosis (suspected bladder tumor) or follow-up of bladder tumor
Exclusion
- Patients managed or followed up for a bladder tumor of non-urothelial histology,
- Renal transplant patients,
- Patient having received pelvic radiotherapy,
- Pregnant or potentially pregnant women (of childbearing age, without effective contraception) or nursing mothers,
- Person in an emergency situation, adult under legal protection (guardianship, curatorship or safeguard of justice), or unable to express consent,
- Inability to undergo medical follow-up for geographical, social or psychological reasons.
Key Trial Info
Start Date :
November 8 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 9 2025
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT06072027
Start Date
November 8 2023
End Date
June 9 2025
Last Update
February 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Paoli-Calmettes
Marseille, France, 13009